You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ROBAXIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Robaxin, and when can generic versions of Robaxin launch?

Robaxin is a drug marketed by Hikma and Endo Operations and is included in two NDAs.

The generic ingredient in ROBAXIN is methocarbamol. There are twenty-seven drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Robaxin

A generic version of ROBAXIN was approved as methocarbamol by PRINSTON INC on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ROBAXIN?
  • What are the global sales for ROBAXIN?
  • What is Average Wholesale Price for ROBAXIN?
Summary for ROBAXIN
Drug patent expirations by year for ROBAXIN
Drug Prices for ROBAXIN

See drug prices for ROBAXIN

Recent Clinical Trials for ROBAXIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 4
Medical College of WisconsinPhase 4

See all ROBAXIN clinical trials

Pharmacology for ROBAXIN

US Patents and Regulatory Information for ROBAXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma ROBAXIN methocarbamol SOLUTION;IM-IV 011790-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations ROBAXIN methocarbamol TABLET;ORAL 011011-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations ROBAXIN-750 methocarbamol TABLET;ORAL 011011-006 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.